| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Donald L Gilbert, MD |
2/2-Anomalous Motor Physiology in ADHD |
National Institutes of Health |
R01 MH095014 |
5/1/2016 - 4/30/2017 |
$267,750 |
| Donald L Gilbert, MD |
Movement-Based Mindfulness Training for Children with ADHD: a Feasibility Study |
National Institutes of Health (Kennedy Krieger Research Institute) |
R21 MH104651 |
8/5/2014 - 6/30/2019 |
$18,082 |
| Tracy A Glauser, MD |
Cincinnati Neuroscience Clinical Trials Research Center |
National Institutes of Health (University of Cincinnati) |
U10 NS077311 |
9/30/2011 - 6/30/2018 |
$153,000 |
| Christina Gross, PHD |
MicroRNA-mediated Silencing of the Kv4.2 Complex in Epilepsy |
National Institutes of Health |
R01 NS092705 |
3/15/2016 - 12/31/2020 |
$331,450 |
| Christina Gross, PHD |
Targeting the PI3K Enhancer PIKE to Reverse FXS-associated Phenotypes |
National Institutes of Health (Emory University) |
R21 MH105353 |
9/1/2014 - 8/31/2016 |
$62,500 |
| Darcy Krueger, MD |
TSC Natural History Database Project |
Tuberous Sclerosis Alliance |
2013DB18Y2 |
1/1/2015 - 12/31/2016 |
$5,147 |
| Darcy Krueger, MD |
Early Biomarkers of Autism Spectrum Disorders in Infants |
National Institutes of Health (Children's Hospital Boston) |
U01 NS082320 |
9/1/2012 - 8/31/2017 |
$608,054 |
| Darcy Krueger, MD |
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations |
National Institutes of Health (Children's Hospital Boston) |
U54 NS092090 |
9/30/2014 - 7/31/2019 |
$79,176 |
| Joseph Krzeski |
Testing microRNA-mediated Silencing of Kv4.2 as Therapeutic Target in an FXS Mouse Model |
National Fragile X Foundation |
FragileX_Krzeski |
5/9/2016 - 8/1/2016 |
$2,500 |
Francis McCormack;Jeffrey A Whitsett, MD
Bruce C Trapnell, MD |
Lung and Cardiovascular Development and Disease Pathogenesis Training Program |
National Institutes of Health |
T32 HL007752 |
7/1/2014 - 6/30/2019 |
$73,747 |
| Diego Morita, MD |
Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE) |
Patient-Centered Outcome Research Inst. (Emory University) |
T069596 |
9/1/2013 - 8/31/2016 |
$3,598 |
| Matthew R Skelton, PHD |
The Role of Na+, K+-ATPase Function in Creatine Transporter Deficiency |
National Institutes of Health |
R21 HD080910 |
9/10/2015 - 8/31/2017 |
$242,784 |
| Shannon Michelle Standridge DO-MPH |
Rett Syndrome, MECP2 Duplication, and Rett Related Disorders Natural History Study |
National Institutes of Health (International Rett Syndrome Foundation) |
U54 HD061222 |
3/1/2016 - 7/1/2019 |
$20,866 |
| Lubov Timchenko, PHD |
Inhibition of GSK3 Beta as Potential Therapy for DM1 |
National Institutes of Health |
R21 AR064488 |
9/20/2014 - 8/31/2017 |
$198,806 |
| Lubov Timchenko, PHD |
The Toxicity of the RNA CGG repeats in FXTAS |
National Institutes of Health |
R21 NS078659 |
6/1/2014 - 8/31/2016 |
$1 |
| Jennifer J Vannest, PHD |
FMRI in Anterior Temporal Epilepsy Surgery |
National Institutes of Health (Medical College of Wisconsin) |
R01 NS035929 |
1/1/2014 - 5/31/2016 |
$36,009 |
| Jennifer J Vannest, PHD |
Imaging the effect of Centrotemporal Spikes and Seizures |
National Institutes of Health |
R01 NS065840 |
9/15/2011 - 6/30/2017 |
$454,454 |
| Charles V Vorhees, PHD |
Annual Meeting of the Neurobehavioral Teratology Society |
Food and Drug Administration |
R13 FD004852 |
7/1/2015 - 6/30/2018 |
$5,000 |
| Charles V Vorhees, PHD |
Transgenerational Inheritance of Epigenetic Effects of Polychlorinated Biphenyls |
University of Cincinnati (University of Cincinnati) |
R21 ES023319 |
8/29/2013 - 7/31/2016 |
$50,546 |
| Charles V Vorhees, PHD |
Teratology Training Grant |
National Institutes of Health |
T32 ES007051 |
7/1/2012 - 6/30/2016 |
$320,186 |
| Total Annual Grant Award Dollars |
$2,933,656 |
